What Are Peptides and How Do They Work?

Quick answer:

Natural peptides are produced inside living organisms — including your own body. Synthetic peptides are built in laboratories using chemical methods. Most research peptides and all licensed peptide medicines available in the UK, including semaglutide, are synthetic. The difference matters because it affects stability, purity, how long a peptide lasts in the body, and how it is regulated under UK law.

If you have ever seen a peptide supplement labelled “natural” and assumed that meant it was safer or more effective, you are not alone.

That assumption is worth questioning.

Some of the most rigorously tested peptide medicines in existence are entirely synthetic. And some natural peptides break down so fast inside the body that they would be useless as treatments.

So what does natural versus synthetic actually mean? And why does it matter for the compounds you read about?

This guide covers both — clearly, with real examples.

What Are Natural Peptides?

Natural peptides are produced by living organisms. Your body makes them constantly.

They act as biological messengers. They carry signals between cells, regulate hormones, help coordinate immune responses, and support nearly every process that keeps you functioning.

Your body produces them in two main ways. The first is called ribosomal synthesis — cells follow genetic instructions to assemble amino acid chains from scratch. The second is enzymatic processing, where larger proteins get broken down into smaller, active peptide fragments.

Here are some examples you will already recognise:

Insulin | Evidence tier: FDA/MHRA approved Produced by the pancreas. Tells your cells to absorb glucose after you eat. Without it, blood sugar regulation breaks down completely.

Oxytocin | Evidence tier: FDA/MHRA approved Sometimes called the bonding hormone. Released during childbirth, breastfeeding, and close social connection. Used medically to help induce labour.

Endorphins | Evidence tier: Well-established physiology Natural peptides released during exercise and stress. They bind to opioid receptors in the brain and reduce pain perception. The “runner’s high” is endorphins at work.

Antimicrobial peptides (AMPs) | Evidence tier: Preclinical and clinical research ongoing Part of your innate immune system. They help destroy bacterial membranes and form a first line of defence against infection.

Natural peptides are biologically precise. They are shaped to fit specific receptors in your body like a key fits a lock.

But there is one major limitation: most of them break down very quickly.

Enzymes in the bloodstream called proteases degrade natural peptides rapidly. Insulin has a plasma half-life of around five minutes. Oxytocin clears the bloodstream within minutes of release. For tight biological regulation inside the body, this is ideal. For therapeutic use, it is a serious problem – you would need near-constant dosing to maintain any meaningful effect.

That is precisely why synthetic peptides were developed.

What Are Synthetic Peptides?

Synthetic peptides are built in laboratories.

Scientists take the amino acid sequence of a natural peptide and reassemble it using chemical methods. Sometimes they copy it exactly. Other times they deliberately modify the sequence to make it more stable, more targeted, or longer-lasting.

The most widely used manufacturing technique is called solid-phase peptide synthesis (SPPS). Here is a simple way to picture it.

Imagine building a necklace, one bead at a time. Each bead is an amino acid. SPPS adds them in a precise sequence one by one to a resin support. When the chain is complete, it is removed and purified. The result is a peptide with a defined sequence, measurable purity, and consistent quality from batch to batch.

SPPS was pioneered byRobert Merrifield in 1963, work that earned him the Nobel Prize in Chemistry in 1984. Modern automated systems can build peptide chains of 30 to 50 amino acids in a matter of days.

Synthetic peptides are not just copies of natural ones. Chemists can make deliberate modifications:

Swap in non-natural amino acids that resist enzymatic breakdown, dramatically extending how long the peptide survives in the body
Add a fatty acid chain to improve tissue binding and extend half-life
Alter the structure to increase selectivity for a specific receptor, reducing unwanted effects elsewhere

The result is often a peptide that behaves like its natural counterpart but performs better in a real-world context.

Semaglutide | Evidence tier: MHRA approved

A synthetic analogue of GLP-1, a natural gut peptide that stimulates insulin release and reduces appetite. Natural GLP-1 has a half-life of less than two minutes. Semaglutide, through structural modification and the addition of a fatty acid chain, has a half-life of approximately 165 hours — which is what makes once-weekly dosing possible. TheSTEP 1 trial published in the New England Journal of Medicine found semaglutide at 2.4 mg produced an average weight reduction of 14.9% over 68 weeks.

BPC-157 | Evidence tier: Preclinical

A synthetic 15-amino acid peptide derived from a naturally occurring protein fragment found in human gastric juice. Scientists identified the sequence, isolated it, and reproduced it chemically using SPPS.Research published in Pharmaceutics (2026) describes it as having cytoprotective and regenerative properties across multiple organ systems in preclinical models though it has no completed Phase II human trials to date.

Both compounds are synthetic. Both have natural origins in the sense that they were inspired by naturally occurring sequences. Neither exists in finished therapeutic form in nature.

The Recombinant Middle Ground

Most people think of peptides as either natural or synthetic. But there is a third category that sits between the two — and it explains how many licensed medicines are actually manufactured.

Recombinant peptides are produced using genetically engineered microorganisms, typically bacteria or yeast.

Scientists insert the DNA coding for the desired peptide into the organism. The organism then produces the peptide as part of its normal biological processes. It is extracted, purified, and used as a pharmaceutical ingredient.

Modern insulin is the most familiar example. The insulin prescribed across the UK today is not extracted from pig or cow pancreas, as it was before the 1980s. It is produced byrecombinant E. coli or yeast strains that have been engineered to produce human insulin. The result is chemically identical to what your pancreas makes but manufactured at an industrial scale with consistent quality.

Recombinant methods work well for longer peptides and proteins that are difficult to assemble through pure chemistry. The trade-off is a more complex purification process and some risk of contamination from the host organism.

Chemically synthesised research peptides like BPC-157, GHK-Cu, and TB-500 do not involve a living organism at any stage. This removes the contamination risk and gives manufacturers tighter control over the final sequence and purity.

Key Differences at a Glance

Feature	Natural Peptides	Synthetic Peptides	Recombinant Peptides
Origin	Produced by living organisms	Built chemically in a lab	Produced by engineered microorganisms
Stability	Short half-life, degrades quickly	Can be modified for extended stability	Varies; often similar to natural form
Purity control	Biological variability; harder to standardise	High purity; verified by HPLC	Complex purification required
Customisation	Limited to natural sequences	Fully customisable	Limited to natural-equivalent sequences
UK examples	Endorphins, AMPs	Semaglutide, BPC-157, GHK-Cu, TB-500	Recombinant insulin, growth hormone

The key takeaway is not that one type is superior.

Each serves a different purpose — and those purposes map directly onto how each type is regulated and sourced in the UK.

Why Synthetic Peptides Dominate Research and Medicine

If your body already makes natural peptides, you might ask why synthetic versions have taken over pharmaceutical development.

The answer comes down to three things: stability, purity, and control.

Stability. Most natural peptides break down within minutes. Synthetic modifications can extend half-life from minutes to days. This is not about making a peptide artificial. It is about making it functional outside the tightly controlled environment of a living cell.

Purity. Because synthetic peptides are assembled from defined chemical components, their purity can be measured precisely. Every batch can be verified using HPLC before it is used in research. When you see a certificate of analysis for a research peptide, the purity figure reflects the quality of that synthesis process. Natural extracts cannot offer the same level of consistency. You can learn more about reading a COA in our guide to peptide certificates of analysis.

Control. Synthetic production lets researchers study one specific sequence in isolation. Natural sources contain a mixture of related peptides and proteins that complicate experimental results. A synthetic peptide with a verified sequence removes that noise.

What This Means Under UK Regulation

This is the part most articles do not cover — and it is arguably the most important section for anyone in the UK navigating the peptide landscape.

The natural versus synthetic distinction does not determine legality in the UK.

What matters is how a compound is classified and what it is sold for.

Under theHuman Medicines Regulations 2012, a substance becomes a regulated medicine when it is presented as having medicinal properties or sold for use in humans. This applies equally to natural and synthetic peptides.

In practice, the UK framework creates three clear tracks:

Track 1: Licensed prescription medicines Synthetic peptides that have passed clinical trials and received MHRA approval. Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) sit here. You need a valid prescription to use them legally. Obtaining them without one is not permitted.

Track 2: Research-use compounds Synthetic peptides like BPC-157, TB-500, and GHK-Cu. They hold no MHRA marketing authorisation for human use. Under UK law, they can be legally purchased for legitimate laboratory research purposes — provided they carry no therapeutic claims and are labelled for research use only. The “for research use only” label is a regulatory position, not a marketing disclaimer.

Track 3: Food supplement peptides Collagen peptides sold as supplements sit here. The Food Standards Agency regulates these as food products, not medicines. Claims about treating or preventing disease are still prohibited, but the evidence threshold is far lower than for a licensed medicine.

The MHRA’s enforcement focus is on suppliers who market Track 2 compounds using medical language. Selling BPC-157 as a treatment for joint pain or a recovery agent almost certainly crosses the legal line. Selling it as a research-use product with no therapeutic claims occupies a different position entirely.

For a full breakdown of how UK peptide law applies across compound categories, see our guide to whether peptides are legal in the UK.

Key Takeaways

The natural versus synthetic divide is less meaningful than it first appears.

What actually matters is the evidence behind a specific compound, its regulatory status in the UK, and the quality of the manufacturing process that produced it.

Natural peptides are fundamental to how your body works. Synthetic peptides are how researchers study, replicate, and improve on those natural processes. Recombinant production sits between the two — and it is how most insulin and growth hormone prescribed across the UK is made today.

If you want to go deeper, explore the full peptide compound index for evidence-tiered profiles of the most researched peptides in the UK, or read our guide to how peptides are made for a closer look at the synthesis process behind the compounds you are researching.

Frequently Asked Questions

Are synthetic peptides safe?

It depends entirely on the specific compound and the evidence behind it. Semaglutide has extensive Phase 3 trial data and a well-characterised safety profile. BPC-157 has decades of animal research but very limited human data. The word synthetic tells you how something was made not whether it is safe. Evidence tier and regulatory status are the relevant variables.

Is semaglutide a natural or synthetic peptide?

Semaglutide is synthetic. It is an engineered analogue of GLP-1, a naturally occurring gut peptide. Natural GLP-1 breaks down within two minutes. Semaglutide has been chemically modified to last approximately a week in the body, enabling once-weekly dosing. It is a licensed prescription medicine in the UK.

Can you get natural peptides from food?

Yes. When you eat protein, your digestive system breaks it down into peptides and amino acids. Collagen peptides from bone broth are a common example. However, most dietary peptides are further digested before they exert any systemic biological effect. Their therapeutic potential is generally modest compared to pharmaceutical-grade synthetic compounds.

What is the difference between a synthetic peptide and a drug?

Not all synthetic peptides are drugs. A drug is a compound that has completed regulatory approval for a specific therapeutic use. Most synthetic research peptides like BPC-157 are not approved drugs — they are research chemicals with preclinical profiles but no licensed indication. Semaglutide is both synthetic and a drug because it has passed clinical trials and received MHRA approval.

Do natural peptides work better than synthetic ones?

Not as a general rule. The insulin used by millions of people with diabetes today is produced recombinantly or synthetically and works better in practice than animal-derived insulin once did, with greater consistency and fewer immune reactions. Effectiveness depends on the compound, the condition, and the quality of the evidence — not on whether the source is natural or synthetic.

References

Davies JS, et al. Peptide therapeutics: oncology and beyond. Signal Transduction and Targeted Therapy. 2022.https://www.nature.com/articles/s41392-022-00904-4
Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine. 2021.https://www.nejm.org/doi/10.1056/NEJMoa2032183
Matica A, et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide. Pharmaceutics. 2025.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11859134/
Fjelstad Pedersen M, et al. BPC-157 as an Investigational Peptide Therapeutic. Pharmaceutics. 2026.https://doi.org/10.3390/pharmaceutics18050625
NIH StatPearls. Biochemistry, Peptide.https://www.ncbi.nlm.nih.gov/books/NBK562260/
UK Human Medicines Regulations 2012.https://www.legislation.gov.uk/uksi/2012/1916/contents
Høeg-Jensen T. Insulin: Recombinant Production, Sustainability, and Chemistry. Oxford Global. 2023.https://oxfordglobal.com/nextgen-biomed/resources/insulin-recombinant-production-sustainability-and-chemistry